Reperio Health Raises $6M in Seed Funding


Reperio Health, a Portland, Oregon-based at-home health assessment and biometric screening system, raised $6m in seed funding.

The round was co-led by Caduceus Capital Partners and Rogue Venture Partners with participation from Liquid 2 Ventures and G Ventures, both out of the San Francisco Bay Area.

The company intends to use the funds to accelerate growth and expand proactive health monitoring to the employer market.

Led by Travis Rush, co-founder and CEO, Reperio Health provides a patent-pending at-home health assessment platform that enables employees and private individuals to perform a broad range of screenings. The FDA-approved sensors in the company’s kit include a blood test to measure levels of total cholesterol, HDL, LDL, triglycerides and glucose, in addition to tests for blood pressure, resting heart rate, Body Mass Index (BMI) and Relative Fat Mass (RFM).

Reperio’s HIPAA-compliant mobile app begins with a wellness screening to understand lifestyle patterns. Then, the biometric screening walks customers through the testing process using voiceovers, animations and videos to make the process possible. Once they complete the full screening, the app provides them real-time results with context that explains their results in a consumer-friendly and easy to understand format.

In addition to their initial launch into the employer market, Reperio’s at-home health assessments will be made available to health plans, retirement facilities, fitness and nutrition practitioners and directly to individuals.

Rush is the former CEO of Sightbox, who sold to Johnson & Johnson in 2017. He is joined at Reperio Health by co-founder and Chief Technology Officer Matt Wallington, also of Sightbox.